{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:37:16Z","timestamp":1791160636819,"version":"4.1.0"},"reference-count":72,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2013,5,8]],"date-time":"2013-05-08T00:00:00Z","timestamp":1367971200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0060566","type":"journal-article","created":{"date-parts":[[2013,5,8]],"date-time":"2013-05-08T21:39:23Z","timestamp":1368049163000},"page":"e60566","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":36,"title":["HIV-1 Tropism Determination Using a Phenotypic Env Recombinant Viral Assay Highlights Overestimation of CXCR4-Usage by Genotypic Prediction Algorithms for CRRF01_AE and CRF02_AG"],"prefix":"10.1371","volume":"8","author":[{"given":"Martin","family":"Mulinge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Lemaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Servais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkadiusz","family":"Rybicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Struck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveline Santos","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Verhofstede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Lie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Seguin-Devaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Schmit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle Perez","family":"Bercoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,5,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/312763a0","article-title":"The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus","volume":"312","author":"AG Dalgleish","year":"1984","journal-title":"Nature"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/381661a0","article-title":"Identification of a major co-receptor for primary isolates of HIV-1","volume":"381","author":"H Deng","year":"1996","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/382833a0","article-title":"The CXC chemokine SDF-1 is the ligand for LESTR\/fusin and prevents infection by T-cell-line adapted HIV-1","volume":"382","author":"E Oberlin","year":"1996","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.272.5263.872","article-title":"HIV-1 entry cofactor : functional cDNA cloning of a seven-transmembrane G protein-coupled receptor","volume":"272","author":"Y Feng","year":"1996","journal-title":"Science"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0092-8674(00)81313-6","article-title":"The [beta]-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates","volume":"85","author":"H Choe","year":"1996","journal-title":"Cell"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/381667a0","article-title":"HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5","volume":"381","author":"T Dragic","year":"1996","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1126\/science.272.5270.1955","article-title":"CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1","volume":"272","author":"G Alkhatib","year":"1996","journal-title":"Science"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/387426a0","article-title":"Atomic structure of the ectodomain from HIV-1 gp41","volume":"387","author":"W Weissenhorn","year":"1997","journal-title":"Nature"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1089\/aid.2006.0130","article-title":"Structural basis of co-receptor selectivity by the HIV-1 V3 loop","volume":"23","author":"T Cardozo","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"9434","DOI":"10.1073\/pnas.89.20.9434","article-title":"Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1","volume":"89","author":"T Shioda","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/34571","article-title":"A newclassification for HIV-1","volume":"391","author":"E Berger","year":"1998","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1089\/aid.2005.21.171","article-title":"V3: HIV&apos;s Switch-Hitter","volume":"21","author":"O Hartley","year":"2005","journal-title":"AIDS Research and Human Retroviruses"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1128\/JVI.80.2.750-758.2006","article-title":"Human immunodeficiency virus type 1 coreceptor switching: V1\/V2 gain-of-fitness mutations compensate for V3 loss-of-fitness mutations","volume":"80","author":"C Pastore","year":"2006","journal-title":"J Virol"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Chalmet K, Dauwe K, Foquet L, Baatz F, Seguin-Devaux C, <etal>et al<\/etal>.. (2011) Presence of CXCR4-Using HIV-1 in Patients With Recently Diagnosed Infection: Correlates and Evidence for Transmission. Journal of Infectious Diseases.","DOI":"10.1093\/infdis\/jir714"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-9-S1-S5","article-title":"Clinical significance of HIV-1 coreceptor usage","volume":"9","author":"H Schuitemaker","year":"2011","journal-title":"Journal of Translational Medicine"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1097\/00002030-199816000-00015","article-title":"Treatment history and baseline viral load, but not viral tropism or CCR-5 genotype, influence prolonged antiviral efficacy of highly active antiretroviral treatment","volume":"12","author":"G Bratt","year":"1998","journal-title":"AIDS"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"7478","DOI":"10.1128\/JVI.71.10.7478-7487.1997","article-title":"Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype","volume":"71","author":"A Bjorndal","year":"1997","journal-title":"J Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1084\/jem.185.4.621","article-title":"Change in coreceptor use correlates with disease progression in HIV-1 infected individuals","volume":"185","author":"RI Connor","year":"1997","journal-title":"J Exp Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1742-4690-7-23","article-title":"Frequent CXCR4 tropism of HIV-1 subtype A and CRF02_AG during late-stage disease - indication of an evolving epidemic in West Africa","volume":"7","author":"J Esbjornsson","year":"2010","journal-title":"Retrovirology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1365-2796.2011.02455.x","article-title":"Human immunodeficiency virus type 1 biological variation and coreceptor use: from concept to clinical significance","volume":"270","author":"EM Feny\u00f6","year":"2011","journal-title":"Journal of Internal Medicine"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1073\/pnas.97.3.1269","article-title":"In vivo HIV-1 infection of CD45RA+CD4+ T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4+ T cell decline","volume":"97","author":"H Blaak","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1056\/NEJMoa0803154","article-title":"Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection","volume":"359","author":"G Fatkenheuer","year":"2008","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJMoa0803152","article-title":"Maraviroc for previously treated patients with R5 HIV-1 infection","volume":"359","author":"R Gulick","year":"2008","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/QAD.0b013e32834113f9","article-title":"Genotypic tropism testing: evidence-based or leap of faith","volume":"25","author":"PR Harrigan","year":"2011","journal-title":"AIDS"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Kuhmann SE, Hartley O (2008) Targeting chemokine receptors in HIV: A status report. Annual Review of Pharmacology and Toxicology. 425\u2013461.","DOI":"10.1146\/annurev.pharmtox.48.113006.094847"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1128\/JVI.02006-06","article-title":"Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry","volume":"81","author":"M Westby","year":"2007","journal-title":"J Virol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e21535","DOI":"10.1371\/journal.pone.0021535","article-title":"Impact of the HIV-1 Genetic Context outside HR1\/HR2 on Resistance to the Fusion Inhibitor Enfuvirtide and Viral Infectivity in Clinical Isolates","volume":"6","author":"F Baatz","year":"2011","journal-title":"PLoS ONE"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.virol.2006.11.004","article-title":"HIV-1 clones resistant to a small molecule CCR5 inhibitor use the inhibitor-bound form of CCR5 for entry","volume":"361","author":"P Pugach","year":"2007","journal-title":"Virology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/COH.0b013e328322f973","article-title":"Current tests to evaluate HIV-1 coreceptor tropism","volume":"4","author":"JD Rose","year":"2009","journal-title":"Current Opinion in HIV & AIDS"},{"key":"ref30","first-page":"94","article-title":"An Enhanced-Sensitivity Trofile\u2122 HIV Coreceptor Tropism Assay for Selecting Patients for Therapy with Entry Inhibitors Targeting CCR5: A Review of Analytical and Clinical Studies","volume":"3","author":"JD Reeves","year":"2009","journal-title":"The Journal of Viral Entry"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1128\/AAC.00853-06","article-title":"Development and characterization of a novel single-cycle recombinant-virus assay to determine human immunodeficiency virus type 1 coreceptor tropism","volume":"51","author":"JM Whitcomb","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jviromet.2007.06.003","article-title":"HIV-1 coreceptor usage determination in clinical isolates using clonal and population-based genotypic and phenotypic assays","volume":"146","author":"K Van Baelen","year":"2007","journal-title":"J Virol Methods"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jviromet.2010.06.012","article-title":"The design and validation of a novel phenotypic assay to determine HIV-1 coreceptor usage of clinical isolates","volume":"169","author":"NH Lin","year":"2010","journal-title":"Journal of Virological Methods"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1128\/JVI.75.1.251-259.2001","article-title":"Determination of coreceptor usage of human immunodeficiency virus type 1 from patient plasma samples by using a recombinant phenotypic assay","volume":"75","author":"V Trouplin","year":"2001","journal-title":"J Virol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jcv.2009.11.018","article-title":"Development and performance of a new recombinant virus phenotypic entry assay to determine HIV-1 coreceptor usage","volume":"47","author":"S Raymond","year":"2010","journal-title":"Journal of Clinical Virology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-1293.2011.00971.x","article-title":"British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011","volume":"13","author":"D Asboe","year":"2012","journal-title":"HIV Medicine"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1128\/JCM.02090-06","article-title":"Population-Based Sequencing of the V3 Region of env for Predicting the Coreceptor Usage of Human Immunodeficiency Virus Type 1 Quasispecies","volume":"45","author":"P Delobel","year":"2007","journal-title":"Journal of Clinical Microbiology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1093\/nar\/gkg575","article-title":"Geno2pheno: estimating phenotypic drug resistance from HIV-1 genotypes","volume":"31","author":"N Beerenwinkel","year":"2003","journal-title":"Nucleic Acids Research"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"13376","DOI":"10.1128\/JVI.77.24.13376-13388.2003","article-title":"Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loopsequences","volume":"77","author":"M Jensen","year":"2003","journal-title":"J Virol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S1473-3099(10)70319-4","article-title":"European guidelines on the clinical management of HIV-1 tropism testing","volume":"11","author":"LPR Vandekerckhove","year":"2011","journal-title":"The Lancet Infectious Diseases"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"McGovern RA, Harrigan PR, Swenson LC (2010) Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3. J Vis Exp: e2531.","DOI":"10.3791\/2531"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1128\/AAC.00148-10","article-title":"Evaluation of the genotypic prediction of HIV-1 coreceptor use versus a phenotypic assay and correlation with the virological response to maraviroc: the ANRS GenoTropism study","volume":"54","author":"P Recordon-Pinson","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/QAI.0b013e3181d0558f","article-title":"Improved detection of CXCR4-using HIV by V3 genotyping: application of population-based and &quot;deep&quot; sequencing to plasma RNA and proviral DNA","volume":"54","author":"LC Swenson","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1128\/JCM.01611-07","article-title":"Evaluation of Eight Different Bioinformatics Tools To Predict Viral Tropism in Different Human Immunodeficiency Virus Type 1 Subtypes","volume":"46","author":"C Garrido","year":"2008","journal-title":"Journal of Clinical Microbiology"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1128\/JCM.02439-08","article-title":"Genotypic Prediction of HIV-1 CRF02-AG Tropism","volume":"47","author":"S Raymond","year":"2009","journal-title":"J Clin Microbiol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1742-4690-8-56","article-title":"Genotypic prediction of HIV-1 subtype D tropism","volume":"8","author":"S Raymond","year":"2011","journal-title":"Retrovirology"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1093\/bioinformatics\/bti607","article-title":"An automated genotyping system for analysis of HIV-1 and other microbial sequences","volume":"21","author":"T de Oliveira","year":"2005","journal-title":"Bioinformatics"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jviromet.2004.09.003","article-title":"A genotypic resistance assay for the detection of drug resistance in the human immunodeficiency virus type 1 envelope gene","volume":"123","author":"K Van Laethem","year":"2005","journal-title":"Journal of Virological Methods"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1468-1293.2011.00922.x","article-title":"Concordance between HIV-1 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA","volume":"12","author":"C Verhofstede","year":"2011","journal-title":"HIV Medicine"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1089\/08892220050058399","article-title":"HIV type 1 envelope subtype C sequences from recent seroconverters in Zimbabwe","volume":"16","author":"M Batra","year":"2000","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1742-6405-6-20","article-title":"Detection of HIV-1 RNA\/DNA and CD4 mRNA in feces and urine from chronic HIV-1 infected subjects with and without anti-retroviral therapy","volume":"6","author":"AK Chakrabarti","year":"2009","journal-title":"AIDS Res Ther"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"10074","DOI":"10.1128\/JVI.74.21.10074-10080.2000","article-title":"Human Immunodeficiency Virus Type 1 Spinoculation Enhances Infection through Virus Binding","volume":"74","author":"U O'Doherty","year":"2000","journal-title":"Journal of virology"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/jmv.21425","article-title":"Improvement in the determination of HIV-1 tropism using the V3 gene sequence and a combination of bioinformatic tools","volume":"81","author":"N Chueca","year":"2009","journal-title":"Journal of Medical Virology"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/jac\/dkq137","article-title":"High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists","volume":"65","author":"E Secl\u00e9n","year":"2010","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/1743-422X-7-280","article-title":"Co-receptor usage and prediction of V3 genotyping algorithms in HIV-1 subtype B&apos; from paid blood donors experienced anti-retroviral therapy in Chinese central province","volume":"7","author":"S Qu","year":"2010","journal-title":"Virol J"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jac\/dkr438","article-title":"Evaluation of genotypic tropism prediction tests compared with in vitro co-receptor usage in HIV-1 primary isolates of diverse subtypes","volume":"67","author":"E Delgado","year":"2012","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/jac\/dkp063","article-title":"Design and validation of new genotypic tools for easy and reliable estimation of HIV tropism before using CCR5 antagonists","volume":"63","author":"E Poveda","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Poveda E, Briz V, Roulet V, del Mar Gonzalez M, Faudon J-L, <etal>et al<\/etal>.. (2007) Correlation between a phenotypic assay and three bioinformatic tools for determining HIV co-receptor use. AIDS 21: 1487\u20131490 1410.1097\/QAD.1480b1013e32826fb32741.","DOI":"10.1097\/QAD.0b013e32826fb741"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/QAI.0b013e3181734f0e","article-title":"Performance of a population-based HIV-1 tropism phenotypic assay and correlation with V3 genotypic prediction tools in recent HIV-1 seroconverters","volume":"48","author":"C de Mendoza","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref60","first-page":"4","article-title":"[Variability in HIV viral tropism determination using different genotypic algorithms in patients infected with B versus non-B HIV-1 subtypes]","volume":"29","author":"JJ Rodriguez","year":"2011","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"F11","DOI":"10.1097\/QAD.0b013e32830ebcd4","article-title":"Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism","volume":"22","author":"S Raymond","year":"2008","journal-title":"AIDS"},{"key":"ref62","first-page":"5","article-title":"Genotypic Prediction of HIV-1 CRF01-AE Tropism","volume":"5","author":"S Raymond","year":"2012","journal-title":"J Clin Microbiol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1128\/JVI.76.8.3852-3864.2002","article-title":"Variability in the Human Immunodeficiency Virus Type 1 gp120 Env Protein Linked to Phenotype-Associated Changes in the V3 Loop","volume":"76","author":"NG Hoffman","year":"2002","journal-title":"Journal of Virology"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1126\/science.1118398","article-title":"Structure of a V3-containing HIV-1 gp120 core","volume":"310","author":"CC Huang","year":"2005","journal-title":"Science"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1128\/JVI.78.1.524-530.2004","article-title":"Intrapatient Alterations in the Human Immunodeficiency Virus Type 1 gp120 V1V2 and V3 Regions Differentially Modulate Coreceptor Usage, Virus Inhibition by CC\/CXC Chemokines, Soluble CD4, and the b12 and 2G12 Monoclonal Antibodies","volume":"78","author":"AA Nabatov","year":"2004","journal-title":"Journal of Virology"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nri2801","article-title":"Structure-function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design","volume":"10","author":"S Zolla-Pazner","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"7682","DOI":"10.1073\/pnas.95.13.7682","article-title":"The ability of HIV type 1 to use CCR-3 as a coreceptor is controlled by envelope V1\/V2 sequences acting in conjunction with a CCR-5 tropic V3 loop","volume":"95","author":"TM Ross","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1089\/aid.2005.21.371","article-title":"The X4 phenotype of HIV type 1 evolves from R5 in two children of mothers, carrying X4, and is not linked to transmission","volume":"21","author":"P Clevestig","year":"2005","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1128\/JVI.78.7.3279-3295.2004","article-title":"N-Linked Glycosylation of the V3 Loop and the Immunologically Silent Face of gp120 Protects Human Immunodeficiency Virus Type 1 SF162 from Neutralization by Anti-gp120 and Anti-gp41 Antibodies","volume":"78","author":"RA McCaffrey","year":"2004","journal-title":"Journal of Virology"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"13433","DOI":"10.1074\/jbc.M009779200","article-title":"N-Linked Glycosylation of the HIV Type-1 gp120 Envelope Glycoprotein as a Major Determinant of CCR5 and CXCR4 Coreceptor Utilization","volume":"276","author":"G Pollakis","year":"2001","journal-title":"Journal of Biological Chemistry"},{"key":"ref71","unstructured":"Hamy F, Vidal V, Hubert S, Klimkait T (2007) Hybridization-based assay and replicative phenotyping as diagnostic platform for determination of coreceptor tropism. 5th European HIV drug resistance workshop: Abstract 60."},{"key":"ref72","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/jac\/dkq379","article-title":"A sensitive phenotypic assay for the determination of human immunodeficiency virus type 1 tropism","volume":"65","author":"N Gonzalez","year":"2010","journal-title":"J Antimicrob Chemother"}],"updated-by":[{"DOI":"10.1371\/annotation\/7c0b830d-e75d-4128-ab54-7d5ecfd99d19","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2013,7,2]],"date-time":"2013-07-02T00:00:00Z","timestamp":1372723200000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0060566","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,26]],"date-time":"2020-07-26T13:33:45Z","timestamp":1595770425000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0060566"}},"subtitle":[],"editor":[{"given":"Zhiwei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,5,8]]},"references-count":72,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,5,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0060566","relation":{"correction":[{"id-type":"doi","id":"10.1371\/annotation\/7c0b830d-e75d-4128-ab54-7d5ecfd99d19","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,8]]}}}